Biogened SA (BGD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BIOTON SA

Biogened SA

Celon Pharma SA

Ryvu Therapeutics SA

Captor Therapeutics SA

Synthaverse SA

Bioceltix SA

Molecure SA

E-shopping Group SA

Why is Biogened SA ?

High Debt Company with a Debt to Equity ratio (avg) at times

High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 8.84% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

ROCE(HY) Lowest at 10.75%
DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
RAW MATERIAL COST(Y) Grown by 6.98% (YoY)

With ROE of 10.45%, it has a fair valuation with a 1.33 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -35.71%, its profits have risen by 2.5% ; the PEG ratio of the company is 5.2

Below par performance in long term as well as near term

Along with generating -35.71% returns in the last 1 year, the stock has also underperformed Poland WIG in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Biogened SA should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Biogened SA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biogened SA

-35.71%

-0.20

46.45%

Poland WIG

27.62%

1.38

19.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.73%

EBIT Growth (5y)

26.71%

EBIT to Interest (avg)

4.85

Debt to EBITDA (avg)

1.29

Net Debt to Equity (avg)

0.40

Sales to Capital Employed (avg)

1.73

Tax Ratio

33.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

16.92%

ROE (avg)

8.84%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.33

EV to EBIT

9.58

EV to EBITDA

6.30

EV to Capital Employed

1.23

EV to Sales

0.69

PEG Ratio

5.19

Dividend Yield

105.04%

ROCE (Latest)

12.85%

ROE (Latest)

10.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at 32.9 %

-6What is not working for the Company

ROCE(HY)

Lowest at 10.75%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

RAW MATERIAL COST(Y)

Grown by 6.98% (YoY

DIVIDEND PER SHARE(HY)

Lowest at PLN 7.16

EPS(Q)

Lowest at PLN 0

Here's what is working for Biogened SA

Debt-Equity Ratio

Lowest at 32.9 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation

Highest at PLN 1.15 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (PLN MM)

Here's what is not working for Biogened SA

EPS

Lowest at PLN 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (PLN)

Dividend per share

Lowest at PLN 7.16

in the last five years

MOJO Watch

Company is distributing lower dividend than previous years

DPS (PLN)

Dividend Payout Ratio

Lowest at 0%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Grown by 6.98% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales